Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 13NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 9Genitourinary 5Breast 4Sarcoma 2Head & Neck 2Plasma cell 1Other solid neoplasm 1Lymphoid 1Gynecologic 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Fluorouracil 74Leucovorin 48Oxaliplatin 44Cisplatin 40Capecitabine 39Gemcitabine 37Radiotherapy 30Irinotecan 28Cetuximab 21Paclitaxel 15Bevacizumab 12Docetaxel 10Taxes 9durvalumab 8dehydroftorafur 8Surgical Procedures, Operative 8Mitomycin 8Specimen Handling 7Platinum 7Folfox protocol 7Carboplatin 7Albumin-Bound Paclitaxel 7130-nm albumin-bound paclitaxel 7S 1 (combination) 6Panitumumab 6Watchful Waiting 5Imatinib Mesylate 5Gene Expression Profiling 5Epirubicin 5tremelimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Reverse Transcriptase Polymerase Chain Reaction × Gastrointestinal × Clear all
NCT00897754 2017-05-19

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

Eastern Cooperative Oncology Group

Completed
200 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡